Delivery Order SPE2DB20D9329-SPE2DB24FZK88

Award Date 7/15/24
Potential Completion Date 8/5/24
Potential Value $7.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,313.48 firm fixed-price delivery order is for the supply of EYLEA 2 MG/0.05 ML VIAL 0.05ML, with a period of performance through August 26, 2024. This award is part of a larger indefinite delivery contract (IDC) under the DLA's SPE2DB program, valued at up to $499,999,999 and running through...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,626.96 firm fixed-price delivery order contract is for the supply of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a pharmaceutical product. This delivery order is part of a larger single-award indefinite delivery contract (IDC) held by DMS Pharmaceutical Group Inc. with DLA under the SPE2DB program, valued...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $15,761.76 firm fixed-price delivery order is for the supply of EYLEA 2 MG/0.05 ML VIAL 0.05ML to support the recurring medical supply needs of military health facilities worldwide. This award is part of a larger $499,999,999 indefinite delivery contract (IDC) under the DLA's SPE2DB program, which...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense (DoD), to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a pharmaceutical product, with a ceiling value of $3,940.44 and a performance period running through June 28, 2024. This award is part of a...
This federal contract award is for the delivery of EYLEA 2 MG/0.05 ML VIAL 0.05ML pharmaceutical products to the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The contract, valued at $2,626.96, was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This is a firm fixed-price delivery order contract with no set-aside designation. DMS Pharmaceutical Group holds a significant indefinite delivery...
This federal contract award is for the delivery of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) under a firm fixed-price delivery order. The contract, valued at $54,016.00, has an ultimate completion date of July 28, 2023, and was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order, valued at $2,626.96, is for the supply of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a specialized pharmaceutical product. This award is made under a larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which allows DMS Pharmaceutical Group to...
The federal contract award is for the supply of EYLEA 2 MG/0.05 ML SYRINGE 0.05ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award, valued at $31,006.32, was made to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA, valued at $499,999,999 and valid through November 2026. The...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,880.88 firm fixed-price delivery order is for the supply of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a pharmaceutical product. The contract is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This single-award...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $16,338.24, is for the supply of EYLEA 2 MG/0.05 ML VIAL 0.05ML to the DLA. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999, which runs through December 31, 2025. The IDC allows the...
  • SPE2DB20D9329
    Indefinite Delivery Contract
  • SPE2DB20D9329-SPE2DB24FZK88
    Delivery Order

This federal contract award is for the delivery of Eylea 2 mg/0.05 ml vial (0.05 ml) to the Defense Logistics Agency (DLA). The contract, valued at $7,880.88, was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois.

The contract is a firm fixed-price delivery order under the DLA's SPE2DB program, which is an indefinite delivery contract (IDC) with a ceiling value of up to $499,999,999 and runs through December 31, 2025. Through this IDC, DMS Pharmaceutical Group provides a comprehensive range of pharmaceutical products, including both common and specialized medications, to support the diverse medical supply needs of military healthcare facilities worldwide. The contract has no set-aside designation.

Generated 1/9/25, 9:17 AM